MAPT and tauopathy: We also show that co-incubation of microglia with an anti-tau monoclonal antibody previously shown to effectively reduce the development of NFTs in a human tauopathy mouse model following passive immunization29, 30, markedly enhances microglia-mediated uptake and degradation of pathological tau, a process that requires Fc effector function.